Hoshino Hitomi, Ohta Makoto, Ito Makoto, Uchimura Kenji, Sakai Yasuhiro, Uehara Takeshi, Low Shulin, Fukushima Mana, Kobayashi Motohiro
Department of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.
Department of Pathology, Fukui Red Cross Hospital, Fukui, Japan.
Lab Invest. 2016 Dec;96(12):1246-1255. doi: 10.1038/labinvest.2016.104. Epub 2016 Oct 17.
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver neoplasm, followed by hepatocellular carcinoma. ICC can be further subclassified as (i) perihilar and (ii) peripheral types, the latter histologically resembling small-sized intrahepatic bile ducts, such as interlobular bile ducts, cholangioles/ductules and the canals of Hering. Cholangiolocellular carcinoma (CoCC), now classified by the World Health Organization as a subtype of combined hepatocellular-cholangiocarcinoma, is currently regarded as a subtype of peripheral-type ICC. The present study was undertaken to determine whether sulfated glycans recognized by the MECA-79 monoclonal antibody could serve as a CoCC marker. Using immunohistochemistry, we show that MECA-79 sulfated glycans are preferentially expressed at the apical membrane of cholangiocytes found in small-sized intrahepatic bile ducts in normal liver and in canalicular structures formed in CoCC. We also report that apical membrane MECA-79 sulfated glycan expression colocalizes with that of mucin 1 (MUC1) core proteins. We also present immunoblotting of Chinese hamster ovary cells overexpressing FLAG-tagged MUC1 to show that MUC1 serves as a MECA-79 scaffold. Furthermore, we report that SSP-25 human ICC cells overexpressing N-acetylglucosamine-6-O-sulfotransferase 2 (GlcNAc6ST-2), but not GlcNAc6ST-1, exhibit membrane expression of MECA-79 sulfated glycans, suggesting that GlcNAc6ST-2 catalyzes MECA-79 epitope biosynthesis in cholangiocytes. Moreover, both wild-type and GlcNAc6ST-1 knockout mice exhibit apical membrane MECA-79 expression in small-sized intrahepatic bile ducts, namely interlobular bile ducts, whereas MECA-79 expression was completely absent in comparable tissues from GlcNAc6ST-1 and GlcNAc6ST-2 double knockout mice. These data collectively indicate that apical membrane localization of MUC1 proteins decorated with GlcNAc6ST-2-dependent MECA-79 sulfated glycans may mark cholangiocytes with cholangiolar/ductular differentiation and could serve as a useful CoCC marker.
肝内胆管癌(ICC)是第二常见的原发性肝脏肿瘤,仅次于肝细胞癌。ICC可进一步细分为(i)肝门部和(ii)外周型,后者在组织学上类似于小叶间胆管、胆小管/细胆管和赫林管等小尺寸肝内胆管。胆管细胞癌(CoCC),目前被世界卫生组织归类为肝细胞-胆管癌的一种亚型,目前被视为外周型ICC的一种亚型。本研究旨在确定MECA-79单克隆抗体识别的硫酸化聚糖是否可作为CoCC的标志物。通过免疫组织化学,我们发现MECA-79硫酸化聚糖优先表达于正常肝脏中小尺寸肝内胆管的胆管细胞顶膜以及CoCC中形成的胆小管结构。我们还报告称,顶膜MECA-79硫酸化聚糖表达与粘蛋白1(MUC1)核心蛋白的表达共定位。我们还展示了过表达FLAG标签MUC1的中国仓鼠卵巢细胞的免疫印迹,以表明MUC1作为MECA-79的支架。此外,我们报告称,过表达N-乙酰葡糖胺-6-O-磺基转移酶2(GlcNAc6ST-2)而非GlcNAc6ST-1的SSP-25人ICC细胞表现出MECA-79硫酸化聚糖的膜表达,这表明GlcNAc6ST-2催化胆管细胞中MECA-79表位的生物合成。此外,野生型和GlcNAc6ST-1基因敲除小鼠在小尺寸肝内胆管即小叶间胆管中均表现出顶膜MECA-79表达,而在GlcNAc6ST-1和GlcNAc6ST-2双基因敲除小鼠的类似组织中则完全没有MECA-79表达。这些数据共同表明,由GlcNAc6ST-2依赖性MECA-79硫酸化聚糖修饰的MUC1蛋白的顶膜定位可能标记具有胆小管/细胆管分化的胆管细胞,并可作为一种有用的CoCC标志物。